| First Author | Dao KH | Year | 2012 |
| Journal | Blood | Volume | 120 |
| Issue | 2 | Pages | 323-34 |
| PubMed ID | 22653977 | Mgi Jnum | J:327850 |
| Mgi Id | MGI:6868077 | Doi | 10.1182/blood-2011-11-388355 |
| Citation | Dao KH, et al. (2012) FANCL ubiquitinates beta-catenin and enhances its nuclear function. Blood 120(2):323-34 |
| abstractText | Bone marrow failure is a nearly universal complication of Fanconi anemia. The proteins encoded by FANC genes are involved in DNA damage responses through the formation of a multisubunit nuclear complex that facilitates the E3 ubiquitin ligase activity of FANCL. However, it is not known whether loss of E3 ubiquitin ligase activity accounts for the hematopoietic stem cell defects characteristic of Fanconi anemia. Here we provide evidence that FANCL increases the activity and expression of beta-catenin, a key pluripotency factor in hematopoietic stem cells. We show that FANCL ubiquitinates beta-catenin with atypical ubiquitin chain extension known to have nonproteolytic functions. Specifically, beta-catenin modified with lysine-11 ubiquitin chain extension efficiently activates a lymphocyte enhancer-binding factor-T cell factor reporter. We also show that FANCL-deficient cells display diminished capacity to activate beta-catenin leading to reduced transcription of Wnt-responsive targets c-Myc and Cyclin D1. Suppression of FANCL expression in normal human CD34(+) stem and progenitor cells results in fewer beta-catenin active cells and inhibits expansion of multilineage progenitors. Together, these results suggest that diminished Wnt/beta-catenin signaling may be an underlying molecular defect in FANCL-deficient hematopoietic stem cells leading to their accelerated loss. |
